Anticoagulation and platelet activation in hemodialysis: clinical results with PMMA.
Coli
L
L
St. Orsola University Hospital, Bologna, Italy.
Cianciolo
G
G
Feliciangeli
G
G
De Sanctis
L B
LB
Zanchelli
F
F
Dalmastri
V
V
De Pascalis
A
A
Sestigiani
E
E
Donati
G
G
Stefoni
S
S
D000368:Aged; D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use*; D001672:Biocompatible Materials / Q000737:chemistry; D001777:Blood Coagulation / Q000187:drug effects*; D001792:Blood Platelets / Q000378:metabolism; D048429:Cell Size; D005260:Female; D006493:Heparin / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000628:therapy; D008297:Male; D008567:Membranes, Artificial; D008875:Middle Aged; D015539:Platelet Activation; D010976:Platelet Count; D010978:Platelet Factor 4 / Q000032:analysis / Q000378:metabolism; D019904:Polymethyl Methacrylate / Q000737:chemistry; D006435:Renal Dialysis / Q000009:adverse effects / Q000295:instrumentation*; D012701:Serotonin / Q000097:blood / Q000378:metabolism; D013927:Thrombosis / Q000517:prevention & control; D001620:beta-Thromboglobulin / Q000032:analysis
D000925:Anticoagulants; D001672:Biocompatible Materials; D008567:Membranes, Artificial; D001620:beta-Thromboglobulin; D012701:Serotonin; D010978:Platelet Factor 4; D006493:Heparin; D019904:Polymethyl Methacrylate